The outbreak of severe acute respiratory syndromecoronavirus-2, the cause of coronavirus disease 2019 (COVID-19) in December 2019 represented a global emergency accounting for more than 2.5 million deaths worldwide.1 It has had an unprecedented influence on cardiac surgery internationally, resulting in cautious delivery of surgery and restructuring of services.2 Understanding the influence of COVID-19 on patients after cardiac surgery is based on assumptions from other surgical specialties and single-center studies. The COVIDSurg Collaborative conducted a multicenter cohort study, including 1128 patients, across 235 hospitals, from 24 countries demonstrating perioperative COVID-19 infection was associated with an overall mortality of 24% and postoperative pulmonary complications in half of all patients.3 Cardiac surgery arguably represents a higher risk population than general or orthopedic surgery due to the high American Society of Anesthesiologists grades and multiple comorbidities usually seen. We present a subgroup analysis of COVIDSurg data, including patients who underwent cardiac surgery between March 1, 2020, and July 31, 2020, across 13 countries, with a confirmed perioperative (7 days preoperative up to 30 days postoperative) diagnosis of COVID-19 infection. This is presented in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology statement for cohort studies.4 Categorical variables were expressed as frequency and percentages and c2 or Fisher exact test was used to compare categorical variables. Only anonymized data were collected. Patient consent was obtained unless it was waived by local research committees. In the United Kingdom, the study was registered at each site as either a clinical audit or service evaluation and consent was waived. In other countries, local investigators were responsible for contacting research ethics committees to obtain local or national approvals in line with applicable regulations
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: an international cohort study / Akowuah, Enoch; Benson, Ruth A.; Caruana, Edward J.; Chetty, Govind; Edwards, John; Forlani, Stefano; Gradinariu, George; Murphy, Gavin J.; Oo, Aung Ye; Patel, Akshay J.; Ridley, Brenda; Rogers, Luke J.; Sanders, Julie; Tyson, Nathan; Vaja, Ricky; Perinotti, R; Maiello, F; Gordini, L; Lombardi, Cp; Marzi, F; Marra, Aa; Ratto, C; Di Muro, M; Litta, F; De Simone, V; Cozza, V; Rosa, F; Agnes, A; Parello, A; Alfieri, S; Sganga, G; Lapolla, P; Mingoli, A; De Toma, G; Fiori, E; La Torre, F; Sapienza, P; Brachini, G; Cirillo, B; Iannone, I; Zambon, M; Chiappini, A; Meneghini, S; Fonsi, Gb; Cicerchia, Pm; Bruzzaniti, P; Santoro, A; Frati, A; Marruzzo, G; Ribuffo, D; Sagnotta, A; Marino Cosentino, L; Mancini, S; Lisi G, Spoletini D; Bellato, V Campanelli M; Sica, G; Siragusa, L; Bonavina, L; Asti, E; Bernardi, D; Lovece, A; Perra, T; Porcu, A; Fancellu, A; Feo, Cf; Scanu, Am; Tuminello, F; Galleano, R; Franceschi, A; Langone, A; Fleres, F; Spolini, A; Bordoni, P; Franzini, M; Clarizia, G; Grechi, A; Longhini, A; Guaitoli E, Manca G; Grossi, U; Novello, S; Zanus, G; Romano, M; Rossi, S; Ferrara, F; Familiari, P; Gallo, Gaetano. - In: JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. - ISSN 0022-5223. - 162:2(2021), pp. 355-372. [10.1016/j.jtcvs.2021.03.091]
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: an international cohort study
Lapolla P;Mingoli A;De Toma G;Fiori EMembro del Collaboration Group
;La Torre FMembro del Collaboration Group
;Sapienza PMembro del Collaboration Group
;Cirillo B;Iannone IMembro del Collaboration Group
;Zambon MMembro del Collaboration Group
;Chiappini AMembro del Collaboration Group
;Meneghini S;Cicerchia PM;Bruzzaniti P;Santoro AMembro del Collaboration Group
;Frati A;Marruzzo GMembro del Collaboration Group
;Ribuffo D;Sagnotta A;Familiari P;GALLO, Gaetano
2021
Abstract
The outbreak of severe acute respiratory syndromecoronavirus-2, the cause of coronavirus disease 2019 (COVID-19) in December 2019 represented a global emergency accounting for more than 2.5 million deaths worldwide.1 It has had an unprecedented influence on cardiac surgery internationally, resulting in cautious delivery of surgery and restructuring of services.2 Understanding the influence of COVID-19 on patients after cardiac surgery is based on assumptions from other surgical specialties and single-center studies. The COVIDSurg Collaborative conducted a multicenter cohort study, including 1128 patients, across 235 hospitals, from 24 countries demonstrating perioperative COVID-19 infection was associated with an overall mortality of 24% and postoperative pulmonary complications in half of all patients.3 Cardiac surgery arguably represents a higher risk population than general or orthopedic surgery due to the high American Society of Anesthesiologists grades and multiple comorbidities usually seen. We present a subgroup analysis of COVIDSurg data, including patients who underwent cardiac surgery between March 1, 2020, and July 31, 2020, across 13 countries, with a confirmed perioperative (7 days preoperative up to 30 days postoperative) diagnosis of COVID-19 infection. This is presented in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology statement for cohort studies.4 Categorical variables were expressed as frequency and percentages and c2 or Fisher exact test was used to compare categorical variables. Only anonymized data were collected. Patient consent was obtained unless it was waived by local research committees. In the United Kingdom, the study was registered at each site as either a clinical audit or service evaluation and consent was waived. In other countries, local investigators were responsible for contacting research ethics committees to obtain local or national approvals in line with applicable regulationsFile | Dimensione | Formato | |
---|---|---|---|
Akowuah_Early-outcomes_2021.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
686.2 kB
Formato
Adobe PDF
|
686.2 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.